Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1]
Kremers WK, Van Ljperem M, Kim WR, Freeman RB, Harper AM, Kamath PS, et al..
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients..
Hepatology. , 39 (2004), pp. 764-9
[2]
De la Mata M, Cuende N, Huet J, Bernardos A, Ferron JA, Santoyo J, et al..
Model for end-stage liver score-based allocation of donors for liver transplantation: a Spanish multicenter experience..
Transplantation. , 82 (2006), pp. 1429-35
[3]
Rodriguez-Roisin R, Krowka MJ, Herve Ph, Fallon MB, on behalf of the ERS task force PHD Scientific committee..
Pulmonary-hepatic vascular disorders (PHD)..
Eur Respir J. , 24 (2004), pp. 861-80
[4]
Mandell MS..
Clinical controversies surrounding the diagnosis and treatment of hepatopulmonary syndrome..
Minerva Anestesiol. , 73 (2007), pp. 347-55
[5]
Mandell MS..
Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era..
Liver Transplant. , 10 (2004), pp. S54-S58
[6]
Schenk P, Schöniger-Kelele M, Fuhrmann V, Madl C, Silberhumer G, Müller C..
Prognostic significance of the heopatopulmonary syndrome in patients with cirrhosis..
Gastroenterology. , 125 (2003), pp. 1042-52
[7]
Swanson KL, Wiesner RH, Krowka MJ..
Natural history of hepatopulmonary syndrome: impact of liver transplantation..
Hepatology. , 41 (2005), pp. 1122-9
[8]
Taillé C, Cadranel J, Bellocq A, Thabut G, Soubrane O, Durand F, et al..
Liver transplantation for hepatopulmonary syndrome: a tenyear experience in Paris, France..
Transplantation. , 75 (2003), pp. 1482-9
[9]
Arguedas MR, Abrahams GA, Krowka MJ, Fallon MB..
Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation..
Hepatology. , 37 (2003), pp. 192-7
[10]
United Network for Organ Sharing..
Policy 3.6.5.4.1. Liver candidates with hepatopulmonary syndrome [citado 2 mayo 2004]. Disponible en: http://www..
unos. , (org/policies and bylaws/policies/doc),
[11]
Krowka MJ, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, et al..
Hepatopulmonary syndrome. A prospective study of relationship between severity of liver disease, PaO2 response to 100% oxygen and brain uptake after 99mTc-MAA lung scanning..
Chest. , 18 (2001), pp. 615-24
[12]
Egawa H, Kashara M, Inomata Y, Uemoto S, Asonuma K, Fujita S, et al..
Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications..
Transplantation. , 15 (1999), pp. 712-5
[13]
Schiffer E, Majno P, Mentha G, Giostra E, Burri H, Klopfenstein CE, et al..
Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: a prospective study in 90 patients..
Am J Transpl. , 6 (2006), pp. 1430-7
[14]
Prince MI, Hudson M..
Liver transplantation for chronic liver disease: advances and controversias in era of organ shortage..
Postgrad Med J. , 78 (2002), pp. 135-41
[15]
Council on ethical and judicial affaire..
American Medical Association Ethical demand for liver transplantation..
Clin Transpl. , 11 (1997), pp. 49-55
[16]
Murray KF, Carithers RL Jr..
AASLD practice guidelines: evaluation of the patient for liver transplantation..
Hepatology. , 41 (2005), pp. 1407-32
[17]
Beresford TP..
What is addiction, what is alcoholism? Liver Transpl..
, 13 Suppl 2 (2007), pp. S55-S58
[18]
Carithers RL Jr, Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, et al..
Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial..
Ann Intern Med. , 110 (1989), pp. 685-90
[19]
Mathurin P, Mendenhall CL, Carithers RL Jr, Ramond MJ, Maddrey WC, Garstide P, et al..
Corticosteroids improve shortterm survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH..
J Hepatol. , 36 (2002), pp. 480-7
[20]
Rincón D, Lo Iacono O, Ripoll C, Gomez-Camarero J, Salcedo M, Catalina MV, et al..
Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis..
Aliment Pharmacol Ther. , 25 (2007), pp. 841-8
[21]
Wells JT, Said A, Agni R, Tomé S, Hughes S, Dureja P, et al..
The impact of acute alcoholic hepatitis in the explanted recipient liver on outcome after liver transplantation..
Liver Transpl. , 13 (2007), pp. 1728-35
[22]
Tome S, Martinez-Rey C, Gonzalez-Quintela A, Abdulkader I, Otero E, Forteza J, et al..
Influence of superimposed alcoholic hepatitis on the outcome of liver transplantation for end-stage alcoholic liver disease..
J Hepatol. , 36 (2002), pp. 793-6
[23]
Lucey MR..
Is liver transplantation an appropriate treatment for acute alcoholic hepatitis? J Hepatol..
, 36 (2002), pp. 829-31
[24]
Hamers FF, Downs AM..
The changing face of the HIV epidemic in western Europe: what are the implications for public health policies? Lancet..
, 364 (2004), pp. 83-94
[25]
Martín-Carbonero L, Soriano V, Valencia E, García-Samaniego J, López M, González-Lahoz J..
Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIVinfected patients..
AIDS Research and Human Retorviruses. , 17 (2001), pp. 1467-71
[26]
González-García JJ, Mahíllo B, Hernández S, Pacheco R, Diz S, García P, et al..
Estudio multicéntrico sobre la prevalencia de las coinfecciones por virus de la hepatitis, indicación de tratamiento de la hepatitis crónica C y necesidad de trasplante hepático en pacientes infectados por VIH en España. Estudio GESIDA 29/02- FIPSE 12185/01..
Enferm Infecc Microbiol Clin. , 23 (2005), pp. 340-8
[27]
Miró JM, Torre-Cisneros J, Moreno A, Tuset M, Quereda C, Laguno M, et al..
GESIDA/GESITRA-SEIMC, SPNS and ONT consensus document on solid organ transplantation (SOT) in HIV-infected patients in Spain-March 2005..
Enferm Infecc Microbiol Clin. , 23 (2005), pp. 353-62
[28]
Pineda JA, Romero-Gomez M, Diaz-Garcia F, Giron-Gonzalez JA, Montero JL, Torre-Cisneros J, et al..
HIV coinfection shortens the survival of patients with hepatitis C virus-related descompensated cirrosis..
Hepatology. , 41 (2005), pp. 779-89
[29]
Ragni MV, Eghtesad B, Schlesinger KW, Dvorchik I, Fung J..
Pretransplante survival is shorter in HIV-positive than HIV negative subjects with end stage liver disease..
Liver Transplantation. , 11 (2005), pp. 1425-30
[30]
De Vera ME, Dvorchik I, Tom K, Eghtesad B, Thai N, Shakil O, et al..
Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C..
Am J Transplant. , 6 (2006), pp. 2983-93
[31]
Sherman KH, Peters M, Koziel MJ..
HIV and liver disease forum: conference proceedings..
Hepatology. , 45 (2007), pp. 1566-77
[32]
Schreibman I, Gaynor JJ, Jayaweera D, Pyrsopoulos N, Weppler D, Tzakis A, et al..
Outcomes after orthotopic liver transplantation in 15 HIV-infected patients..
Transplantation. , 84 (2007), pp. 697-705
[33]
Castells L, Escartin A, Bilbao I, Len O, Allende H, Vargas V, et al..
Liver transplantation in HIV-HCV coinfected patients: a case-control study..
Transplantation. , 83 (2007), pp. 354-8
[34]
Ragni M, Belle SH, Im K, Neff G, Roland M, Stock P, et al..
Survival of human immunodeficiency virus-infected liver transplant recipients..
J Infect Dis. , 188 (2003), pp. 1412-20
[35]
Mindikoglu AL, Regev A, Magder LS..
Impact of HIV on survival after liver transplantation. Analysis of united network for organ sharing (UNOS) database [abstract]..
Hepatology. , 246A (2007),
[36]
Prachalias AA, Pozniak A, Taylor C, Srinivasan P, Muiesan P, Wendon J, et al..
Liver transplantation in adults coinfected with HIV..
Transplantation. , 72 (2001), pp. 1684-8
[37]
Castells LL, Montejo M, Bilbao I, Rafecas A, Rimola A, Fortún J, et al..
Tratamiento de la recidiva de la infección por el virus de la hepatitis C (VHC) posTH con interferón pegilado (Peg-IFN) y Ribavirina (RBV) en los pacientes VIH: resultados preliminares del estudio de cohorte FIPSE OLT-HIV-05-GESIDA (2002-2007)..
Gastroenterol Hepatol. , 30 Suppl2 (2007), pp. 10-2
[38]
Norris S, Taylor C, Muiesan P, Portmann BC, Knisely AS, Bowles M, et al..
Outcomes of liver transplantation in HIV infected individuals: the impact of HCV and HBV infection..
Liver Transplant. , 10 (2004), pp. 1271-8
